Cargando…
Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches
Since Mycoplasma genitalium was identified 40 years ago, much of the epidemiology has been described, diagnostic tests have been developed and approved, and recommended treatment approaches have been identified. However, the natural history remains incompletely understood, and antimicrobial resistan...
Autores principales: | Manhart, Lisa E., Geisler, William M., Bradshaw, Catriona S., Jensen, Jørgen S., Martin, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328920/ https://www.ncbi.nlm.nih.gov/pubmed/35876565 http://dx.doi.org/10.3201/eid2808.220094 |
Ejemplares similares
-
Management of Mycoplasma genitalium infections – can we hit a moving target?
por: Jensen, Jørgen Skov, et al.
Publicado: (2015) -
Azithromycin Failure in Mycoplasma genitalium Urethritis
por: Bradshaw, Catriona S., et al.
Publicado: (2006) -
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
por: Murray, Gerald L., et al.
Publicado: (2017) -
Persistence of Mycoplasma genitalium Following Azithromycin Therapy
por: Bradshaw, Catriona S., et al.
Publicado: (2008) -
Recent advances in understanding and combatting Mycoplasma genitalium
por: Peel, Joanne, et al.
Publicado: (2020)